Juvenile idiopathic arthritis-associated RIG-I S144F variant inhibits type I interferon signaling by blocking TRIM25-mediated ubiquitinationOA
Juvenile idiopathic arthritis(JIA)is a heterogeneous group of idiopathic inflammatory arthritis affecting children before 16 years of age.Although the pathogenesis of JIA remains unclear,viral infection is a potential environmental risk factor in JIA development.The retinoic acid-inducible gene I(RIG-I),a key cytosolic pathogen recognition receptor(PRR)responsible for detecting viral double-stranded RNA(dsRNA),serves as a critical gatekeeper of antiviral immunity through type I interferon(IFN)induction.Recent study suggests that the S144F variant is associated with increased disease severity and poorer treatment outcomes in pediatric rheumatic patients.4 However,the potential contribution and mechanism of RIG-I genetic variants to JIA susceptibility has never been systematically explored.In this study,we show that the RIG-I S144F variant is significantly enriched in JIA patients.S144F variant reduces its binding with the E3 ligase TRIM25,leading to decreased K63-linked polyubiquitination of RIG-I.Consequently,this results in impaired type I interferon signaling activation,higher viral load,and aggravated NF-κB signaling.In summary,we uncover a critical role of the RIG-I S144F variant in suppressing antiviral immunity,and shed light on immune pathogenesis of JIA.
Li Zhang;Song Zhang;Yaoyao Shangguan;Wanming Huang;Haolan Jin;Lili Li;Yuyin Qi;Yuxia Zhang;Ping Zeng;Huifang Xian
Guangzhou Institute of Pediatrics,Guangzhou Women and Children’s Medical Center,Guangzhou Medical University,Guangzhou,Guangdong 510623,ChinaGuangzhou Institute of Pediatrics,Guangzhou Women and Children’s Medical Center,Guangzhou Medical University,Guangzhou,Guangdong 510623,China Department of Allergy,Immunology and Rheumatology,Guangzhou Women and Children’s Medical Center,Guangzhou Medical University,Guangzhou,Guangdong 510623,ChinaThe Second Affiliated Hospital of Wenzhou Medical University,Wenzhou,Guangdong 325000,ChinaGuangzhou Institute of Pediatrics,Guangzhou Women and Children’s Medical Center,Guangzhou Medical University,Guangzhou,Guangdong 510623,ChinaGuangzhou Institute of Pediatrics,Guangzhou Women and Children’s Medical Center,Guangzhou Medical University,Guangzhou,Guangdong 510623,ChinaGuangzhou Institute of Pediatrics,Guangzhou Women and Children’s Medical Center,Guangzhou Medical University,Guangzhou,Guangdong 510623,ChinaGuangzhou Institute of Pediatrics,Guangzhou Women and Children’s Medical Center,Guangzhou Medical University,Guangzhou,Guangdong 510623,ChinaGuangzhou Institute of Pediatrics,Guangzhou Women and Children’s Medical Center,Guangzhou Medical University,Guangzhou,Guangdong 510623,ChinaGuangzhou Institute of Pediatrics,Guangzhou Women and Children’s Medical Center,Guangzhou Medical University,Guangzhou,Guangdong 510623,China Department of Allergy,Immunology and Rheumatology,Guangzhou Women and Children’s Medical Center,Guangzhou Medical University,Guangzhou,Guangdong 510623,ChinaGuangzhou Institute of Pediatrics,Guangzhou Women and Children’s Medical Center,Guangzhou Medical University,Guangzhou,Guangdong 510623,China
医药卫生
juvenile idiopathic arthritis jiaJuvenile Idiopathic ArthritisUbiquitinationantiviral immunityTrimcytosolic pathogen recognitionidiopathic inflammatory arthritisType I Interferon Signaling
《Genes & Diseases》 2026 (4)
P.75-78,4
supported by funding from the National Natural Science Foundation of China(No.32100735)China Postdoctoral Science Foundation(No.2019M663225)Guangdong Provincial Basic and Applied Basic ResearchFoundation(China)(No.2025A1515012735)Guangzhou Municipal Science and Technology Project(China)(No.2024A03J0806).
评论